REGENERON PHARMACEUTICALS INC revenue for the last year amounted to 296.10 B MXN, the most of which — 296.10 B MXN — came from its highest performing source at the moment, Medicines, the year earlier bringing 222.80 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought REGENERON PHARMACEUTICALS INC 150.11 B MXN, and the year before that — 114.71 B MXN.